Raj K. Puri, M.D., Ph.D.

Raj K. Puri, M.D., Ph.D.

Chief Regulatory OfficeratIovance Biotherapeutics· In proxies 2024–2025

Pay in FY2025-58% from the year before · Iovance Biotherapeutics stock -63.1% the same year

Raj K. Puri, M.D., Ph.D. was paid $1.3M in FY2025 (Dec), down 58%. Iovance Biotherapeutics stock fell 63.1% that year.

Pay$100 in the stock at the end of FY23 → $34
Pay is from the Summary Compensation Table of each Iovance Biotherapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Iovance BiotherapeuticsPublic company · 2 yr
    • Chief Regulatory Officer2024 – Present · 2 yrStock in role +67%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?